686 related articles for article (PubMed ID: 28118517)
1. The significance of the washout period in preconditioning.
Salie R; Lochner A; Loubser DJ
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
3. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
Fan WJ; van Vuuren D; Genade S; Lochner A
Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.
Salie R; Moolman JA; Lochner A
Basic Res Cardiol; 2012 Sep; 107(5):281. PubMed ID: 22797560
[TBL] [Abstract][Full Text] [Related]
5. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.
Yang C; Talukder MA; Varadharaj S; Velayutham M; Zweier JL
Cardiovasc Res; 2013 Jan; 97(1):33-43. PubMed ID: 22977010
[TBL] [Abstract][Full Text] [Related]
6. CREB activation and ischaemic preconditioning.
Marais E; Genade S; Lochner A
Cardiovasc Drugs Ther; 2008 Feb; 22(1):3-17. PubMed ID: 18205034
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion.
Salie R; Alsalhin AKH; Marais E; Lochner A
Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348
[TBL] [Abstract][Full Text] [Related]
8. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
[TBL] [Abstract][Full Text] [Related]
9. Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
Lochner A; Marais E; Genade S; Huisamen B; du Toit EF; Moolman JA
Cardiovasc J Afr; 2009; 20(1):43-51. PubMed ID: 19287816
[TBL] [Abstract][Full Text] [Related]
10. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
[TBL] [Abstract][Full Text] [Related]
11. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
Nuñez RE; Javadov S; Escobales N
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
[TBL] [Abstract][Full Text] [Related]
17. Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion.
Rossello X; Riquelme JA; Davidson SM; Yellon DM
J Cell Mol Med; 2018 Feb; 22(2):926-935. PubMed ID: 29159980
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection by the transfer of coronary effluent from ischaemic preconditioned rat hearts: identification of cardioprotective humoral factors.
Maciel L; de Oliveira DF; Verissimo da Costa GC; Bisch PM; Nascimento JHM
Basic Res Cardiol; 2017 Sep; 112(5):52. PubMed ID: 28695353
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection.
Fryer RM; Pratt PF; Hsu AK; Gross GJ
J Pharmacol Exp Ther; 2001 Feb; 296(2):642-9. PubMed ID: 11160653
[TBL] [Abstract][Full Text] [Related]
20. The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC).
Salie R; Moolman JA; Lochner A
Cardiovasc Drugs Ther; 2011 Feb; 25(1):31-46. PubMed ID: 21225332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
